Objective-To investigate whether chromosome 10q11.21 influences common carotid intima-media thickness (IMT) and atherosclerosis and whether it is associated with stromal cell-derived factor-1␣ (SDF-1␣) plasma levels. Methods and Results-Variation on chromosome 10q11.21 has been consistently associated with coronary artery disease.
M ost coronary artery disease (CAD) and stroke cases are caused by advanced atherosclerosis, whose pathogenesis is a long-term process that takes place over many years. These 2 diseases share many genetic and environmental factors. For instance, genomewide association studies (GWASs) have revealed that a DNA sequence variant on chromosome 9p21 increases the risk of both CAD and stroke. [1] [2] [3] [4] [5] Information on the effects of the various genetic and environmental factors on the different stages of atherosclerosis development and progression can advance our understanding of the underlying mechanisms.
Carotid intima-media thickness (IMT) is a reliable marker for early atherosclerosis and predicts future cardiovascular events. 6, 7 Several genetic variants previously shown to be related to risk of CAD and/or stroke have subsequently been reported to be associated with interindividual variability in carotid IMT, 8, 9 suggesting that the influence of these genetic variants on IMT may be a mechanism contributing to altered susceptibility to CAD and/or stroke. However, some other CAD-and stroke-related genetic factors, such as the chromosome 9p21 variant, 10 -12 are not associated with carotid IMT, indicating that they do not affect CAD and stroke risk through a mechanism reflected by changes in carotid IMT.
One of the key loci for CAD, recently identified by a GWAS, is chromosome 10q11.21. 1, 4 This locus lies upstream of the CXCL12 gene, which encodes stromal cell-derived factor-1␣ (SDF-1␣), a chemokine that has a protective effect against atherogenesis. 13 Whether this CAD locus has an influence on carotid IMT is unknown. In this study, we genotyped 3 population cohorts (Bruneck, Health2000, and essential hypertension in families collected in the region of Oxford [HTO]) for single-nucleotide polymorphism (SNP) rs501120 (located at the 10q11.21 locus), which was associated with risk of CAD in a GWAS 1 and in a subsequent large-scale replication study. 14 We then conducted a metaanalysis using data from these cohorts to ascertain whether the SNP was associated with carotid IMT. In addition, in the Bruneck cohort, in which data for carotid atherosclerosis were available, we tested for a potential relationship of rs501120 with the development, severity, and progression of atherosclerosis. Because the CXCL12 gene is located most proximal to SNP rs501120 and its gene product SDF-1␣ may influence atherosclerosis development, we investigated whether there was an association between rs501120 and plasma SDF-1␣ level in the Bruneck cohort, for which data for plasma SDF-1␣ levels were available.
Methods

Subjects
Our study was performed in 3 population cohorts: Bruneck (age range, 45 to 94 years; 50.0% men; nϭ738), 11, [15] [16] [17] [18] Health2000 (age range, 46 to 76 years; 55.4% men; nϭ1237), 10 and HTO (age range, 19 to 88 years; 47.9% men; nϭ770). 19, 20 Carotid IMT was determined by ultrasonographic scanning of common carotid arteries, and the mean carotid IMT in each subject was used in this analysis. 10, [15] [16] [17] 20 In the Bruneck Study, carotid atherosclerosis was also determined as follows. Atherosclerotic lesions were defined according to 2 ultrasonographic criteria: (1) wall surface (protrusion or roughness of the arterial boundary) and (2) wall texture (echogenicity). The maximum axial diameter of plaques (in millimeters) was assessed on the near and far walls at each of 8 vessel segments. The atherosclerosis score, indicative of atherosclerosis severity, was calculated by summing all diameters at 8 well-defined segments of the common and internal carotid arteries. [15] [16] [17] Incident atherosclerotic plaque was defined by development of plaques in segments previously free of atherosclerosis. Atherosclerosis progression was defined as the change in the atherosclerosis score over time. The supplemental data (available online at http://atvb.ahajournals.org) provide further details of the Bruneck, Health2000, and HTO cohorts.
Determination of Genotypes
Genotypes for SNP rs501120 were determined using an SNP genotyping method (TaqMan) with a predeveloped assay (Assay ID C___1033658_10). The nearby SNP rs1746048 was typed in the Bruneck cohort to test linkage disequilibrium (LD), with the use of the KASPar method (Competitive Allele Specific PCR SNP genotyping system). Random duplicates or random repeats were used as a quality control.
Measurements of Plasma SDF-1␣ Levels
Plasma SDF-1␣ levels in the Bruneck cohort were determined. In brief, blood samples were drawn after an overnight fast and 12-hour abstinence from smoking. Plasma from blood samples drawn in 2000 was prepared by centrifuging the blood samples for 15 minutes at 2510 relative centrifugal force. Plasma from blood samples drawn in 2005 was obtained during isolation of mononuclear cells by densitygradient centrifugation (Lymphoprep); plasma was obtained from the upper phase after centrifugation. The plasma samples were stored at Ϫ80°C and immediately used after a single thawing cycle. Plasma SDF-1␣ levels in samples obtained during the 2000 and 2005 examinations were measured using commercially available ELISA kits. The mean minimum detectable concentration by the kit is 18 pg/mL, the standard curve ranges from 0 to 10 ng/mL, and intra-assay and interassay coefficients of variation are approximately 3.5% and 10%, respectively.
Statistical Analysis
The meta-analysis of SNP rs501120 in relation to sex-/age-adjusted common carotid IMT was conducted using a computer program (StatsDirect), which computes pooled effect size (weighted mean difference) and 95% CI, under the fixed-effects (Mulrow-Oxman) model and the random-effects (DerSimonian-Laird) model, respectively. Also, heterogeneity between cohorts was tested (providing Cochran Q and I 2 statistics). Recessive models best fit the data and were used throughout the study.
In the Bruneck Study, relationships of rs501120 genotypes with carotid atherosclerosis, plasma SDF-1␣, and other cardiovascular risk factors were tested using computer software packages (SPSS 15.0 and BMDP). Variables with a skewed distribution were log e transformed to satisfy the assumption of normality and constant variance of the residuals. With the exception of the power calculation, all probability values were 2-sided. The associations of rs501120 genotypes with presence of carotid atherosclerosis, incident atherosclerotic plaques, atherosclerosis score, and atherosclerosis progression were tested by logistic and linear regression analyses. Base models were adjusted for age and sex. Multivariable models were adjusted for presence or absence of hypertension, smoking status, diabetes mellitus, level of alcohol consumption, levels of high-and low-density lipoprotein, body mass index, waist:hip ratio, and high-sensitivity C-reactive protein and lipoprotein(a) levels. SDF-1␣ showed a moderate deviation from a gaussian distribution. Accordingly, log e -transformed SDF-1␣ levels, which approximate a gaussian distribution (Kolmogorov-Smirnov statistics, 0.052 [Pϭ0.052] and 0.036 [Pϭ0.088]) were used in all analyses. The association between plasma SDF-1␣ level and rs501120 genotype was analyzed by general linear models adjusted for age and sex, with log e -transformed SDF-1␣ level used as the dependent variable and the genotype coded as 1 (T/T) or 2 (C/T or C/C). LD between SNPs rs501120 and rs1746048 in the Bruneck cohort was assessed using a computer program (HaploView). The relationships of demographic variables, clinical characteristics, and cardiovascular risk factors with rs501120 genotypes were assessed using general linear and logistic regression models.
Results
Association Between the 10q11 Locus and Carotid IMT
The genotype distributions (Table 1) in the Bruneck, Health2000, and HTO cohorts were all consistent with the Hardy-Weinberg equilibrium, and the allele frequencies were similar to those previously reported in other population samples of European ancestry. 1, 14 Age-and sex-adjusted common carotid IMT values according to the T/T, C/T, and C/C genotypes of the rs501120 SNP in the Bruneck, Health2000, and HTO studies are shown in Table 1 . Individuals with the T/T risk genotype had higher IMT values than those with the C/T or C/C genotype (42, 17, and 11 m, respectively). A meta-analysis using data from the 3 studies showed a statistically significant difference in IMT value between genotypes in a recessive model (T/T versus C/T and C/C): pooled weighted mean difference, 23 m (95% CI, 9 to 37 m; Pϭ0.0014) under a fixed-effects model; and 23 m (95% CI, 6 to 41 m; Pϭ0.009) under a random-effects model (Figure 1 ). There was no significant heterogeneity among the data from the 3 individual cohorts (Pϭ0.240).
Association Between the 10q11 Locus and Carotid Atherosclerosis
In the Bruneck cohort, in which data for carotid atherosclerosis were available, we observed consistent significant relationships between the rs501120 SNP T/T genotype and increased presence, severity, and progression of carotid atherosclerotic plaques. Details are depicted in Table 2 .
Association Between the 10q11 Locus and Plasma SDF-1␣ Level
Because the nearest annotated gene in relation to SNP rs501120 on chromosome 10q11 is CXCL12, which encodes SDF-1␣, we ascertain a relationship between rs501120 and plasma SDF-1␣ level. Data for plasma SDF-1␣ levels were available in the Bruneck cohort but not in the Health2000 and HTO cohorts. In the Bruneck cohort, we observed an asso-ciation between the rs501120 T/T genotype and lower plasma SDF-1␣ level measured in blood samples drawn in 2000 (2.62 ng/mL for the T/T genotype versus 2.74 ng/mL for the C/C or C/T genotype; Pϭ0.023) ( Figure 2 ) and 2005 (2.56 ng/mL for the T/T genotype versus 2.63 ng/mL for the C/C or C/T genotype; Pϭ0.039). When using means of the 2000 and 2005 data, the results were similar (2.58 and 2.68 ng/mL, respectively; Pϭ0.004).
Recently, it was reported that plasma SDF-1␣ level was associated with SNP rs1746048, 21 another SNP located at the 10q11 locus and associated with CAD. 4 In addition, we genotyped the Bruneck cohort for SNP rs1746048 and found that the rs501120 T allele associated with lower SDF-1␣ levels in our study was in LD (r 2 ϭ0.95) with the rs1746048 C allele associated with lower plasma SDF-1␣ levels in the previous study. 21
10q11 Locus, Circulating Endothelial Progenitor Cell Numbers, and Classic Cardiovascular Risk Factors
Because SDF-1␣ is thought to be involved in endothelial progenitor cell (EPC) mobilization, we tested whether there was a relationship between SNP rs501120 and circulating EPC number in the Bruneck cohort, for which such data were available. We observed that circulating EPC numbers were lower in subjects with the T/T genotype than in those with the C/C or C/T genotype (mean EPC number, 428.8 for T/T and 475.3 for C/C or C/T), although the difference did not reach statistical significance (Pϭ0.34).
No significant association was found between the rs501120 genotype and any of the following classic cardiovascular risk factors in the Bruneck Study: smoking status, hypertension, body mass index, diabetes, Framingham risk score, and levels of low-and high-density lipoprotein cholesterol, lipoprotein(a), and C-reactive protein.
Discussion
GWASs have identified chromosome 10q11.21 as a key locus that influences CAD risk. 1, 4 A GWAS by Samani et al 1 showed that the T allele of SNP rs501120, located on chromosome 10q11.21, is associated with increased risk of CAD; this association was replicated in a subsequent largescale study. 14 *Data are given as meanϮSD values (in millimeters) of age-and sex-adjusted carotid IMT. The number of subjects is given in parentheses. of SNP rs501120 is in almost complete LD with the C allele of SNP rs1746048.
Our study shows that the 10q11.21 locus influences common carotid IMT, an early marker for atherosclerosis and a predictor of risk of cardiovascular diseases, including CAD and stroke. 6, 7 This finding indicates that the effect of the 10q11.21 locus on CAD risk may involve pathological remodeling of blood vessel walls, reflected by changes in carotid IMT. This is in contrast to the 9p21 locus that, although associated with CAD risk, [1] [2] [3] has no discernable effect on carotid IMT. 10 -12 Our findings for the 10q11.21 locus extend to definite carotid atherosclerosis, with significant associations detected for presence, severity, and progression of plaques in the Bruneck cohort.
The CAD-related SNPs on chromosome 10q11.21 reside upstream of the CXCL12 gene, which encodes the chemokine SDF-1␣. In the present study, we found an association between the rs501120 T/T genotype and lower SDF-1␣ level. Recently, another study 21 showed that plasma SDF-1␣ levels are associated with SNP rs1746048, which, as previously mentioned, is also located at the 10q11 locus and associated with CAD. 4 We found that the rs501120 risk allele (T allele) associated with lower plasma SDF-1␣ levels in our study was in near-complete LD with the rs1746048 risk allele (C allele) associated with lower plasma SDF-1␣ levels in the previous study, 21 suggesting that these 2 SNPs likely represent the same genetic influence on SDF-1␣ levels. The mechanisms by which these SNPs correlate with SDF-1␣ levels remain unknown. Although these SNPs are approximately 100 kb upstream of the CXCL12 gene, it is possible that they might influence CXCL12 gene expression because gene expression can be influenced by regulatory SNPs located several hundred kilobases upstream or downstream. 22 In relation to this point, the SNPExpress database has recorded an association between SNP rs1746048 and CXCL12 gene mRNA levels (detected by a probe with identification No. 3286608) in peripheral blood mononuclear cells (Pϭ0.0016) (available at: http://people.genome.duke.edu/Ϸdg48/SNPExpress/index.php). *Data are given as regression coefficient (95% CI), except for incident atherosclerosis plaques, for which data are given as odds ratio (95% CI). The T/T genotype was compared with the C/T or C/C genotype (recessive model), derived from logistic and linear regression analyses. Multivariable analyses were adjusted for age, sex, smoking status, hypertension, diabetes mellitus, alcohol consumption, high-and low-density lipoprotein cholesterol levels, body mass index, waist:hip ratio, and log e -transformed concentrations of high-sensitivity C-reactive protein and lipoprotein(a).
†IMT was assessed in plaque-free sections of the left and right common carotid arteries. ‡Atherosclerosis scores, indicative of atherosclerosis severity, were calculated by summing the maximum diameter of atherosclerotic plaques at 8 well-defined segments of common and internal carotid arteries. Log e -transformed atherosclerosis scores were used in the analysis.
§Atherosclerosis progression was defined as the change in the atherosclerosis score between 2000 and 2005. Incident atherosclerotic plaques were defined by the development of plaques in segments previously free of atherosclerosis. Figure 2 . Plasma SDF-1␣ levels according to rs501120 genotype in the Bruneck cohort. Plasma SDF-1␣ levels assessed in samples drawn in 2000 were lower in subjects with the T/T rs501120 genotype (Pϭ0.023). The probability value given was derived from a general linear model adjusted for age and sex, with log e -transformed SDF-1␣ level used as the dependent variable and the rs501120 genotype coded as 1 (T/T) or 2 (C/T or C/C).
SNP rs501120 is not included in this database. Whether these SNPs influence SDF-1␣ levels by affecting CXCL12 mRNA expression or by other mechanisms warrants further studies.
There is evidence suggesting that SDF-1␣ is involved in EPC homing, mobilization, and differentiation [23] [24] [25] ; and that the SDF-1␣ level correlates with circulating EPC number. 26 In a previous study, 27 we showed a significant association of an SNP (rs2297630) that is not in LD with rs501120 (r 2 ϭ0; DЈϭ0.05) located in the CXCL12 gene with plasma SDF-1␣ level and circulating EPC number in the Bruneck cohort. In the present study, we investigated whether SNP rs501120 was associated with circulating EPC number in the Bruneck cohort and observed that circulating EPC numbers were lower in subjects with the T/T genotype than in those with the C/C or C/T genotype; however, the difference did not reach statistical significance.
Because the rs501120 T allele is associated with increased CAD risk 1, 14 and with lower SDF-1␣, and because SDF-1␣ has an antiatherogenic effect, 13, 28, 29 it is conceivable that the effect of the 10q11.21 locus on CAD risk is, to some extent, mediated by an influence on SDF-1␣ production. SDF-1␣ is thought to exert multiple atheroprotective effects beyond EPC trafficking and homing, such as promoting defense and survival programs that counteract apoptosis and facilitating endothelial and vascular integrity. 13 Our study has several merits, including the meta-analysis of common carotid IMT in 3 independent studies and the availability of multiple ultrasonographic measures of carotid vessel pathological features during the follow-up in the Bruneck Study. The present study also has the following limitations. (1) The study was conducted in individuals of European ancestry, and findings may not necessarily apply to other ethnicities or to white populations from geographical regions with a distinct genetic background. (2) Although the study was adequately powered to assess an association between the rs501120 genotype and carotid IMT in our meta-analysis, the sample sizes of the individual studies were on the low side for detection of small IMT differences. To facilitate interpretation of the IMT findings, results of a power calculation are shown in the supplemental data. (3) SDF-1␣ can bind to its receptor on platelets; therefore, measurement of SDF-1␣ in plasma can be affected by contaminations with platelets. 30 -32 Moreover, SDF-1␣ plasma levels are subject to short-and long-term variations and influenced by a variety of circumstances, such as immunoinflammatory and neoplastic diseases. 28, 33 In summary, the results of this study indicate that the CAD-related variation on chromosome 10q11.21 is also associated with carotid IMT, without influencing classic intermediate traits, such as hypercholesterolemia and hypertension. These findings will aid the understanding of the biological mechanisms underlying the effects of this genetic factor. 
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